Dow Gains Over 100 Points; Producer Prices Unchanged In July

Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15

Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $21 to $15.

JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $16

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and lowers the price target from $20 to $16.

DA Davidson Maintains Buy on Cellebrite DI, Lowers Price Target to $15

DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $22 to $15.

Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $12.5

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $15 to $12.5.

Shares of aerospace and defense companies are trading lower. Reports suggest that Deputy Defense Secretary Steve Feinberg signed a memo proposing a software tool that would give the government direct access to defense companies' financial systems, potentially impeding commercial and nontraditional firms from doing business with the Pentagon.

12 Industrials Stocks Moving In Monday's After-Market Session

Gainers Xos (NASDAQ:XOS) shares rose 82.8% to $3.82 during Monday's after-market session. The company's market cap stands at $29.7 million. The company's, Q2 earnings came out 2 days ago. Wetour Robotics